C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.880
-0.090 (-3.03%)
At close: Apr 24, 2026, 4:00 PM EDT
2.890
+0.010 (0.35%)
After-hours: Apr 24, 2026, 4:31 PM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $281.03 million as of April 24, 2026. Its market cap has increased by 228.52% in one year.
Market Cap
281.03M
Enterprise Value
38.54M
1-Year Change
228.52%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $281.03M, a decrease of -63.63%. That is a compound annual growth rate of -16.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 289.81M | 56.56% |
| Dec 31, 2025 | 185.11M | -27.16% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Greenwich LifeSciences | 317.41M |
| NervGen Pharma | 314.01M |
| Artiva Biotherapeutics | 309.95M |
| LENZ Therapeutics | 309.47M |
| Foghorn Therapeutics | 309.35M |
| Abeona Therapeutics | 306.92M |
| Minerva Neurosciences | 305.14M |
| Eledon Pharmaceuticals | 300.83M |